How We Handle Pharma Cold-Chain Shipments End-to-End
By G. JEEVAN RAOSAHIB
Transporting pharmaceuticals is not like moving furniture or electronics. The stakes are higher, the margins for error tighter. And when temperature control enters the picture, every degree matters. Literally.
I remember one of our earliest pharma cold-chain shipments at Indelox Service Private Limited. It was a biologic drugâsensitive to temperature shifts as small as 2°C. We were tasked with moving it from a facility in Hyderabad to a hospital in Dubai, end-to-end. What followed was a lesson in precision, communication, and contingency planning. Since then, weâve fine-tuned a process that we now apply across all pharma cold-chain logistics we handle.
Itâs not magic. But it is meticulous.
Understanding the Product First
Not all pharmaceuticals require refrigeration, but when they do, they demand clarity. So our process begins not with packing, but with listening.
We sit down with the clientâs quality and regulatory teams. What is the exact temperature bandâ2â8°C? 15â25°C? Frozen? What are the critical stability points? How long can the product tolerate excursions? Is the packaging pre-qualified? Are there stability studies we should see?
No two products are identical. Even a minor difference in formulation can change how it must be handled. We donât assume. We ask.
Pre-Planning: Routes, Partners, and Timing
Once we know the product profile, we map the routeânot just by geography, but by risk. Airports, customs, road transfers, weekends, public holidays. We factor it all in.
Then we identify cold-chain capable carriers, handling agents, and lane-tested partners. If even one link in the chain lacks proper cold storage or SOPs for pharma cargo, we look elsewhere. We've walked away from seemingly lucrative contracts simply because the risk didnât justify the reward.
For a recent vaccine shipment from India to East Africa, we chose a route with a longer flight time but fewer handoversâreducing the risk of temperature excursions. It wasnât the fastest way. But it was the safest.
Packaging: It Begins with the Box
Weâre strong believers in passive packaging for many shipments. These are insulated boxes with phase change materials (PCM) or dry ice that maintain temperature without an external power source.
But not all passive solutions are created equal. We only use pre-qualified packaging, validated for the duration and route in question. Some shipments require active containers (powered units with refrigeration), especially for bulk movements or long transits.
We test-run packaging under simulated conditions, using temperature probes to validate duration. A shipment labeled â72-hour holdâ needs to hold for 80+ in our books. Because delays happen.
Data Logging: Proof and Peace of Mind
Every pharma cold-chain shipment we handle includes real-time GPS and temperature monitoring. These arenât just for the client. Theyâre for us too.
We monitor temperature data from our control tower. If an alert triggersâsay, a containerâs internal temp hits 9°Câwe act. Sometimes itâs a warehouse reroute. Sometimes, a rapid customs intervention. Sometimes, just a call to a driver sitting too long under the sun.
A few months ago, we had a shipment headed to Europe flagged at an airport tarmac in the Middle East. The crate was sitting in direct sunlight longer than planned. Our monitoring platform picked up the spike. We triggered an on-ground move via our local agentâand prevented a full load loss.
Every alert doesnât lead to disaster. But the ones we ignore do.
Customs Clearance: Cold Doesnât Wait
Clearing pharma cargo isnât like clearing textile goods. Many cold-chain shipments are shipped under time-sensitive import permits. Some need pre-inspection. Others face random customs exams that can add hours of delay.
Thatâs why we prepare documentation down to the last comma. Certificates of analysis. Temperature logs. Product information sheets. Importer registration. And more.
We also proactively notify customs brokers in the receiving countryâwhether itâs Ghana, the UAE, or the EU. Because a customs officer working on a Friday afternoon needs more than documentsâthey need context. We provide both.
Last-Mile Delivery: The Final 5%
The productâs made it through multiple airports, warehouses, and inspectionsâbut the job isnât over.
Final-mile cold-chain delivery requires trained staff, temperature-controlled vehicles, and, in many cases, delivery to hospitals, pharmacies, or research labs that donât operate on logistics schedules.
We once delivered a clinical trial drug to a research center in northern Indiaâafter hours, during monsoon rains, in a van that had to be re-routed because of flooding. But the cargo arrived, temperature intact, within the protocol window.
Why? Because we had a driver trained not just in routing, but in responsibility.
Audit Trails and SOP Reviews
Every shipment ends with a reportânot just a âProof of Delivery,â but a post-mortem. Did we stay within temperature limits? Were there alarms? What was the total time in transit? What lessons can we apply next time?
Pharma clients expect this. And frankly, we do too. Because the job isnât just about one shipment. Itâs about trust.
The Go Global Perspective
This year, Indelox Service Private Limited is proud to be a nominee for the 2025 Go Global Awards, being held in London on November 18â19. Hosted by the International Trade Council, the event gathers leaders across industries to share, learn, and connect.
Why mention that here?
Because pharma logistics, like global business, is built on collaboration. No one firm can claim to control every risk. But togetherâwith regulators, manufacturers, carriers, and partnersâwe create a cold-chain ecosystem that actually works.
And when the product is life-saving, itâs not just logistics. Itâs a responsibility.














